Who should be first in line for the COVID-19 vaccine? Surveys in 13 countries of the public’s preferences for prioritisation

Raymond Duch, Laurence Roope, Mara Violato, Matias Fuentes Becerra, Thomas Robinson, Jean‐François Bonnefon, Jorge Friedman, Peter John Loewen, Pavan Mamidi, Alessia Melegaro, Mariana Blanco, Juan F. Vargas, Julia Seither, Paolo Candio, Ana Gibertoni Cruz, Xinyang Hua, Adrian Barnett, Philip ClarkemedRxiv 2021 · DOI

Abstract

How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients that varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favours giving priority to a broad range of key workers and to those on lower incomes. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favoured COVID-19 vaccines being allocated solely via government programs, but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination which needs to be taken into account when developing and communicating roll-out strategies.

Introduction

As COVID-19 vaccines became available in early 2021, governments worldwide faced a critical scarcity problem: demand far outstripped supply. Policymakers had to decide which groups to prioritize—the elderly, essential workers, or the economically vulnerable. While international organizations provided ethical frameworks, understanding public perception of "fairness" was crucial for ensuring campaign success and avoiding polarization. This study provides an empirical map of public preferences across 13 diverse countries to guide these high-stakes decisions.

Methodology

The researchers utilized a conjoint experiment involving 15,536 participants from the Oxford COVID-19 Vaccine Preference and Opinion Survey (CANDOUR) Project. Countries included Australia, Brazil, Canada, Chile, China, Colombia, France, India, Italy, Spain, Uganda, the UK, and the USA.

Participants evaluated pairs of hypothetical vaccine recipient profiles that varied across five key attributes: occupation, age, transmission risk, risk of death (vulnerability), and income level. By making over 248,000 binary choices, the dataset allowed researchers to calculate the relative importance assigned to each attribute using logistic regression.

Global Consensus on Prioritization

The study revealed a surprising level of international agreement. Across all 13 countries, health and social care workers were consistently given the highest priority. There was also a strong preference for prioritizing those at high clinical risk (vulnerability) and those with a high risk of transmitting the virus.

Table 1: Summary of prioritization criteria across the 13 surveyed countries.

Beyond clinical factors, the public showed a significant "economic" priority. In almost every country, individuals in the lowest 20% income bracket and "key workers" (such as teachers or factory workers who cannot work from home) were prioritized over higher-income groups. Interestingly, these preferences were altruistic: high-income respondents prioritized the poor, and younger respondents generally supported prioritizing the elderly.

A notable exception was China, where respondents preferred younger recipients (ages 25 and 40) over the elderly. This may reflect different cultural valuations of economic productivity versus vulnerability or the specific demographic makeup of the sample.

The Mandate Gap and Policy Implications

While there was consensus on who should receive the vaccine, the how remained deeply divisive. In every country, at least two-thirds of the population agreed that vaccines should be distributed solely through government programs. However, the issue of government mandates was highly polarized. While respondents in China, India, and Uganda strongly supported mandates, Western nations like the US and UK were split, and France showed overwhelming opposition.

Conclusion

The findings suggest that public trust can be bolstered by aligning rollout strategies with these shared values of fairness. Highlighting how prioritization plans protect the economically vulnerable and essential workers—not just the medically at-risk—could increase public buy-in. However, the polarization surrounding mandates suggests that a "one-size-fits-all" communication strategy may be ineffective in Western contexts.

Summary updated

Abstract

ABSTRACT How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients that varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favours giving priority to a broad range of key workers and to those on lower incomes. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favoured COVID-19 vaccines being allocated solely via government programs, but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination which needs to be taken into account when developing and communicating roll-out strategies.
BibTeX
@misc{duch2021who,
  author = {Raymond Duch and Laurence Roope and Mara Violato and Matias Fuentes Becerra and Thomas Robinson and Jean‐François Bonnefon and Jorge Friedman and Peter John Loewen and Pavan Mamidi and Alessia Melegaro and Mariana Blanco and Juan F. Vargas and Julia Seither and Paolo Candio and Ana Gibertoni Cruz and Xinyang Hua and Adrian Barnett and Philip Clarke},
  title = {{Who should be first in line for the COVID-19 vaccine? Surveys in 13 countries of the public’s preferences for prioritisation}},
  year = {2021},
  doi = {10.1101/2021.01.31.21250866},
  howpublished = {medRxiv},
}
Figure